Madison Investment Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Madison Investment Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-42,000	Closed	-$2.2M	–	224
2014 Q2	$2.2M	Sell	42,000 -53,000	-56%	-$2.71M	0.05%	162
2014 Q1	$5.02M	Hold	95,000	–	–	0.1%	146
2013 Q4	$3.81M	Sell	95,000 -70,000	-42%	-$2.76M	0.07%	156
2013 Q3	$6.23M	Hold	165,000	–	–	0.13%	136
2013 Q2	$6.47M	Buy	+165,000	New	+$6.43M	0.14%	124

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Madison Investment Holdings's TEVA Position: Q3 2014 in Review

Madison Investment Holdings sold out of Teva Pharmaceuticals (TEVA) in Q3 2014, closing a stake of 42,000 shares — an estimated $2.2M sold.

Madison Investment Holdings first reported a position in TEVA in Q2 2013 and held it in 5 quarters. The position peaked at $6.47M in Q2 2013. 773 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.

Madison Investment Holdings reported no remaining Teva Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
Madison Investment Holdings sold 42,000 Teva Pharmaceuticals shares in Q3 2014, an estimated $2.2M.
Madison Investment Holdings first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 5 quarters.
Madison Investment Holdings's Teva Pharmaceuticals position peaked at $6.47M in Q2 2013.
773 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2014.

Based on Madison Investment Holdings's 13F filing for Q3 2014, filed 10 Nov 2014.